Group One Trading’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.1M | Sell |
47,900
-39,100
| -45% | -$6.75M | 0.02% | 982 |
|
|
2025
Q4 | $15.9M | Sell |
87,000
-10,900
| -11% | -$1.52M | 0.03% | 663 |
|
|
2025
Q3 | $11.9M | Sell |
97,900
-1,200
| -1% | -$135K | 0.02% | 796 |
|
|
2025
Q2 | $10.3M | Sell |
99,100
-12,600
| -11% | -$1.33M | 0.02% | 793 |
|
|
2025
Q1 | $13M | Sell |
111,700
-41,000
| -27% | -$4.67M | 0.04% | 499 |
|
|
2024
Q4 | $12.9M | Buy |
152,700
+41,300
| +37% | +$3.8M | 0.03% | 556 |
|
|
2024
Q3 | $10M | Buy |
111,400
+33,700
| +43% | +$2.94M | 0.03% | 617 |
|
|
2024
Q2 | $6.25M | Sell |
77,700
-7,300
| -9% | -$540K | 0.02% | 673 |
|
|
2024
Q1 | $6.78M | Buy |
85,000
+16,400
| +24% | +$1.38M | 0.03% | 631 |
|
|
2023
Q4 | $5.46M | Sell |
68,600
-16,300
| -19% | -$1.09M | 0.01% | 1063 |
|
|
2023
Q3 | $5.93M | Sell |
84,900
-8,600
| -9% | -$643K | 0.02% | 837 |
|
|
2023
Q2 | $6.72M | Buy |
93,500
+43,600
| +87% | +$3.22M | 0.02% | 754 |
|
|
2023
Q1 | $3.08M | Sell |
49,900
-42,400
| -46% | -$2.79M | 0.01% | 1180 |
|
|
2022
Q4 | $7.12M | Sell |
92,300
-59,200
| -39% | -$3.54M | 0.02% | 933 |
|
|
2022
Q3 | $6.76M | Sell |
151,500
-209,300
| -58% | -$10.5M | 0.01% | 954 |
|
|
2022
Q2 | $13.8M | Sell |
360,800
-5,100
| -1% | -$161K | 0.02% | 661 |
|
|
2022
Q1 | $15.1M | Sell |
365,900
-16,500
| -4% | -$511K | 0.02% | 747 |
|
|
2021
Q4 | $14.4M | Buy |
382,400
+154,400
| +68% | +$5.68M | 0.01% | 847 |
|
|
2021
Q3 | $7.51M | Buy |
228,000
+98,000
| +75% | +$3.82M | 0.01% | 1320 |
|
|
2021
Q2 | $8.77M | Buy |
130,000
+12,600
| +11% | +$756K | 0.01% | 1179 |
|
|
2021
Q1 | $6.65M | Buy |
117,400
+500
| +0.4% | +$35.2K | 0.01% | 1270 |
|
|
2020
Q4 | $9.52M | Sell |
116,900
-43,800
| -27% | -$3.28M | 0.02% | 828 |
|
|
2020
Q3 | $11.4M | Buy |
160,700
+45,100
| +39% | +$3.51M | 0.04% | 455 |
|
|
2020
Q2 | $9.51M | Sell |
115,600
-33,500
| -22% | -$2.58M | 0.04% | 464 |
|
|
2020
Q1 | $8.77M | Sell |
149,100
-58,800
| -28% | -$4.79M | 0.07% | 306 |
|
|
2019
Q4 | $21.5M | Buy |
207,900
+66,400
| +47% | +$2.68M | 0.15% | 131 |
|
|
2019
Q3 | $2.86M | Buy |
141,500
+38,000
| +37% | +$976K | 0.02% | 936 |
|
|
2019
Q2 | $2.67M | Buy |
103,500
+16,000
| +18% | +$321K | 0.02% | 885 |
|
|
2019
Q1 | $1.25M | Buy |
87,500
+85,400
| +4,067% | +$793K | 0.01% | 1259 |
|
|
2018
Q4 | $6K | Sell |
2,100
-500
| -19% | -$1.65K | ﹤0.01% | 4421 |
|
|
2018
Q3 | $9K | Sell |
2,600
-13,900
| -84% | -$41.2K | ﹤0.01% | 4669 |
|
|
2018
Q2 | $53K | Buy |
16,500
+15,500
| +1,550% | +$48K | ﹤0.01% | 3919 |
|
|
2018
Q1 | $2K | Buy |
+1,000
| New | +$2.99K | ﹤0.01% | 4625 |
|
Other funds holding AXSM
VPM
VCM
DTC
Group One Trading's AXSM Position: Q1 2026 in Review
Group One Trading reduced its Axsome Therapeutics (AXSM) stake by 99% in Q1 2026, selling an estimated $3.8M and leaving 214 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5517.
Group One Trading first reported a position in AXSM in Q4 2017 and has held it in 32 quarters since. The position peaked at $15.6M in Q4 2021. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.
- Group One Trading held 214 shares of Axsome Therapeutics worth $36.2K as of Q1 2026.
- Group One Trading sold 21,997 Axsome Therapeutics shares in Q1 2026, an estimated $3.8M.
- Axsome Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5517 holding.
- Group One Trading first reported a position in Axsome Therapeutics in Q4 2017 and has held it in 32 quarters since.
- Group One Trading's Axsome Therapeutics position peaked at $15.6M in Q4 2021.
- 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.